+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rheumatoid Arthritis"

From
From
From
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
Prescriber Opinions on Biosimilars in Immunology - Product Thumbnail Image

Prescriber Opinions on Biosimilars in Immunology

  • Report
  • March 2021
  • 45 Pages
  • Global
From
Digital Health in Immunology - Thematic Research - Product Thumbnail Image

Digital Health in Immunology - Thematic Research

  • Report
  • December 2021
  • 57 Pages
  • Global
From
From
Digital Marketing Trends in Rheumatoid Arthritis - Product Thumbnail Image

Digital Marketing Trends in Rheumatoid Arthritis

  • Report
  • March 2023
  • 36 Pages
  • Global
From
From
From
From
Loading Indicator

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes. The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments. Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more